Neurogene Inc.
43 SEC EDGAR filings indexed (CIK 0001404644) across 14 form types.
Filing profile
Neurogene Inc. (NGNE) has 43 SEC filings indexed on SecFilingDex, across 14 form types filed over roughly 2 years, from November 14, 2024 to August 11, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 31 of these filings were disclosed in the twelve months to August 11, 2026. 6 of the 43 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 88-KMaterial event · event-driven
- 8Form 4Insider transaction · within 2 business days of transaction
- 610-QQuarterly report · quarterly
- 3424B5Prospectus supplement · event-driven
- 3Form 4/AInsider transaction · within 2 business days of transaction
- 2Form 3Initial insider ownership · within 10 days of becoming an insider
- 2DEF 14AProxy statement · annual (pre-meeting)
- 2DEFA14ASEC filing
- 210-KAnnual report · annual
- 2424B3Updated prospectus · event-driven
- 2SC 13G/A5%+ passive stake · event-driven
- 1Form 3/AInitial insider ownership · within 10 days of becoming an insider
- 1SC 13G5%+ passive stake · event-driven
- 1S-1IPO registration · event-driven (pre-ipo)
Profile derived from 43 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- 8-KMaterial event · period of report Aug 11, 2026Filed · 0001404644-26-000056
- 10-QQuarterly report · period of report Jun 30, 2026Filed · 0001404644-26-000059
- Form 4Insider transaction · period of report Jul 6, 2026Filed · 0001543663-26-000017
- 8-KMaterial event · period of report Jun 30, 2026Filed · 0001404644-26-000050
- Form 4Insider transaction · period of report Jul 1, 2026Filed · 0001543663-26-000015
- 424B5Prospectus supplementFiled · 0001628280-26-046666
- 424B5Prospectus supplementFiled · 0001628280-26-046237
- 8-KMaterial event · period of report Jun 29, 2026Filed · 0001404644-26-000046
- Form 3/AInitial insider ownership · period of report Dec 18, 2023Filed · 0001996804-26-000008
- Form 4/AInsider transaction · period of report Jun 12, 2025Filed · 0001996804-26-000009
- Form 4/AInsider transaction · period of report Jun 14, 2024Filed · 0001996804-26-000010
- Form 4/AInsider transaction · period of report Jan 16, 2024Filed · 0001996804-26-000011
- 8-KMaterial event · period of report Jun 8, 2026Filed · 0001404644-26-000044
- 8-KMaterial event · period of report Jun 3, 2026Filed · 0001404644-26-000040
- 10-QQuarterly report · period of report Mar 31, 2026Filed · 0001404644-26-000037
- 8-KMaterial event · period of report May 12, 2026Filed · 0001404644-26-000038
- Form 4Insider transaction · period of report May 6, 2026Filed · 0001543663-26-000013
- Form 4Insider transaction · period of report May 5, 2026Filed · 0001934412-26-000006
- 8-KMaterial event · period of report Apr 20, 2026Filed · 0001404644-26-000030
- Form 3Initial insider ownership · period of report Apr 20, 2026Filed · 0001934412-26-000004
- DEF 14AProxy statement · period of report Jun 3, 2026Filed · 0001404644-26-000027
- DEFA14ASEC filingFiled · 0001404644-26-000028
- Form 4Insider transaction · period of report Mar 26, 2026Filed · 0001543663-26-000011
- Form 4Insider transaction · period of report Mar 26, 2026Filed · 0001606302-26-000005
- Form 4Insider transaction · period of report Mar 26, 2026Filed · 0001968554-26-000005
- 8-KMaterial event · period of report Mar 24, 2026Filed · 0001404644-26-000012
- 10-KAnnual report · period of report Dec 31, 2025Filed · 0001404644-26-000019
- Form 4Insider transaction · period of report Mar 13, 2026Filed · 0001994301-26-000004
- 10-QQuarterly report · period of report Sep 30, 2025Filed · 0001404644-25-000101
- 10-QQuarterly report · period of report Jun 30, 2025Filed · 0001404644-25-000081
- 424B5Prospectus supplementFiled · 0001628280-25-039623
- 10-QQuarterly report · period of report Mar 31, 2025Filed · 0001404644-25-000041
- DEF 14AProxy statement · period of report Apr 25, 2025Filed · 0001404644-25-000034
- DEFA14ASEC filingFiled · 0001404644-25-000035
- 424B3Updated prospectusFiled · 0001628280-25-015981
- 10-KAnnual report · period of report Dec 31, 2024Filed · 0001404644-25-000012
- 424B3Updated prospectusFiled · 0001628280-24-051855
- SC 13G5%+ passive stakeFiled · 0001493152-24-049633
- S-1IPO registrationFiled · 0001628280-24-049615
- SC 13G/A5%+ passive stakeFiled · 0001104659-24-123711
- Form 3Initial insider ownership · period of report Nov 25, 2024Filed · 0001415889-24-027859
- 10-QQuarterly report · period of report Sep 30, 2024Filed · 0001404644-24-000104
- SC 13G/A5%+ passive stakeFiled · 0001172661-24-005298
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.